Postpartum contraceptive choice and fulfillment in patients with opioid use disorder

doi:10.1016/j.contraception.2023.110267

. 2023 Dec:128:110267.

doi: 10.1016/j.contraception.2023.110267. Epub 2023 Aug 24.

Postpartum contraceptive choice and fulfillment in patients with opioid use disorder

Kathryn N Thomas¹, Tani Malhotra², David Ngendahimana³, Kelly S Gibson⁴, Kavita S Arora⁵

Affiliations

¹ Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA; Department of Obstetrics, Gynecology & Reproductive Sciences, UPMC Magee-Womens Hospital, Pittsburgh, PA, USA. Electronic address: thomaskn2@upmc.edu.
² Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA; Department of Obstetrics and Gynecology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
³ Office of Mental Health and Suicide Prevention, Veterans Health Administration, Menlo Park, CA, USA.
⁴ Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA.
⁵ Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA; Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, USA.

PMID: 37633590
PMCID: PMC10873085
DOI: 10.1016/j.contraception.2023.110267

Postpartum contraceptive choice and fulfillment in patients with opioid use disorder

Kathryn N Thomas et al. Contraception. 2023 Dec.

. 2023 Dec:128:110267.

doi: 10.1016/j.contraception.2023.110267. Epub 2023 Aug 24.

Authors

Kathryn N Thomas¹, Tani Malhotra², David Ngendahimana³, Kelly S Gibson⁴, Kavita S Arora⁵

Affiliations

¹ Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA; Department of Obstetrics, Gynecology & Reproductive Sciences, UPMC Magee-Womens Hospital, Pittsburgh, PA, USA. Electronic address: thomaskn2@upmc.edu.
² Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA; Department of Obstetrics and Gynecology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
³ Office of Mental Health and Suicide Prevention, Veterans Health Administration, Menlo Park, CA, USA.
⁴ Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA.
⁵ Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH, USA; Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, USA.

PMID: 37633590
PMCID: PMC10873085
DOI: 10.1016/j.contraception.2023.110267

Abstract

Objective: We examined the differences in postpartum contraception between patients with and without opioid use disorder (OUD).

Study design: We conducted a retrospective, single-institution, cohort analysis assessing differences in desired method of postpartum contraception and plan fulfillment.

Results: Patients with OUD comprised 200/8654 (2.3%) of our study cohort. After 2:1 matching, method desired (matched odds ratio [mOR] 0.86, 95% confidence interval [CI] 0.60-1.23 for highly vs. moderately effective) and receipt (mOR 0.77, 95% CI 0.53-1.12) of desired method were comparable between groups.

Conclusion: Patients with and without OUD were similar in their choice and fulfillment of postpartum contraception.

Keywords: Long-acting reversible contraception; Opioid use disorder; Postpartum contraception; Postpartum visit attendance; Unintended pregnancy.

PubMed Disclaimer

Conflict of interest statement

Declarations of interest: none.

References

1. Collier KW, MacAfee LK, Kenny BM, Meyer MC. Does co-location of medication assisted treatment and prenatal care for women with opioid use disorder increase pregnancy planning, length of interpregnancy interval, and postpartum contraceptive uptake? J Subst Abuse Treat. 2019;98:73–77. doi:10.1016/j.jsat.2018.12.001 - DOI - PubMed
1. Fischbein RL, Lanese BG, Falletta L, Hamilton K, King JA, Kenne DR. Pregnant or recently pregnant opioid users: contraception decisions, perceptions and preferences. Contracept Reprod Med. 2018;3:4. doi:10.1186/s40834-018-0056-y - DOI - PMC - PubMed
1. Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011;40(2):199–202. doi:10.1016/j.jsat.2010.08.011 - DOI - PMC - PubMed
1. Parlier AB, Fagan B, Ramage M, Galvin S. Prenatal care, pregnancy outcomes, and postpartum birth control plans among pregnant women with opiate addictions. South Med J. 2014;107(11):676–683. doi:10.14423/SMJ.0000000000000189 - DOI - PubMed
1. Smith C, Morse E, Busby S. Barriers to Reproductive Healthcare for Women With Opioid Use Disorder. J Perinat Neonatal Nurs. 2019;33(2):E3–E11. doi:10.1097/JPN.0000000000000401 - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Collier KW, MacAfee LK, Kenny BM, Meyer MC. Does co-location of medication assisted treatment and prenatal care for women with opioid use disorder increase pregnancy planning, length of interpregnancy interval, and postpartum contraceptive uptake? J Subst Abuse Treat. 2019;98:73–77. doi:10.1016/j.jsat.2018.12.001 - DOI - PubMed

[2] Collier KW, MacAfee LK, Kenny BM, Meyer MC. Does co-location of medication assisted treatment and prenatal care for women with opioid use disorder increase pregnancy planning, length of interpregnancy interval, and postpartum contraceptive uptake? J Subst Abuse Treat. 2019;98:73–77. doi:10.1016/j.jsat.2018.12.001 - DOI - PubMed

[3] Fischbein RL, Lanese BG, Falletta L, Hamilton K, King JA, Kenne DR. Pregnant or recently pregnant opioid users: contraception decisions, perceptions and preferences. Contracept Reprod Med. 2018;3:4. doi:10.1186/s40834-018-0056-y - DOI - PMC - PubMed

[4] Fischbein RL, Lanese BG, Falletta L, Hamilton K, King JA, Kenne DR. Pregnant or recently pregnant opioid users: contraception decisions, perceptions and preferences. Contracept Reprod Med. 2018;3:4. doi:10.1186/s40834-018-0056-y - DOI - PMC - PubMed

[5] Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011;40(2):199–202. doi:10.1016/j.jsat.2010.08.011 - DOI - PMC - PubMed

[6] Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011;40(2):199–202. doi:10.1016/j.jsat.2010.08.011 - DOI - PMC - PubMed

[7] Parlier AB, Fagan B, Ramage M, Galvin S. Prenatal care, pregnancy outcomes, and postpartum birth control plans among pregnant women with opiate addictions. South Med J. 2014;107(11):676–683. doi:10.14423/SMJ.0000000000000189 - DOI - PubMed

[8] Parlier AB, Fagan B, Ramage M, Galvin S. Prenatal care, pregnancy outcomes, and postpartum birth control plans among pregnant women with opiate addictions. South Med J. 2014;107(11):676–683. doi:10.14423/SMJ.0000000000000189 - DOI - PubMed

[9] Smith C, Morse E, Busby S. Barriers to Reproductive Healthcare for Women With Opioid Use Disorder. J Perinat Neonatal Nurs. 2019;33(2):E3–E11. doi:10.1097/JPN.0000000000000401 - DOI - PubMed

[10] Smith C, Morse E, Busby S. Barriers to Reproductive Healthcare for Women With Opioid Use Disorder. J Perinat Neonatal Nurs. 2019;33(2):E3–E11. doi:10.1097/JPN.0000000000000401 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Postpartum contraceptive choice and fulfillment in patients with opioid use disorder

Affiliations

Postpartum contraceptive choice and fulfillment in patients with opioid use disorder

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Abstract

Conflict of interest statement

Similar articles

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical